API CAS 24729-96-2 Clindamycin Pharmaceutical Clindamycin

• Customization: Available
• CAS No.: 24729-96-2
• Formula: C18h34cln2o8PS
• Model NO.: QS-Clindamycin
• EINECS: 246-433-0
• Packaging Material: Negotiable
• Storage Method: Normal
• Shelf Life: >12 Months
• Nutrient Composition: Clindamycin
• Resource: Clindamycin
• The content of active substances: >99%
• Product Name: Clindamycin
• Name: Clindamycin Powder
• Colour: White
• Grade: Pharmaceutical Grade
• Assay: >99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Density: 1.41
• Mf: C18h34cln2o8PS
• MW: 504.96
• Melting Point: 114c
• Boiling Point: 159c
• Specific Rotation: +115at+130
• Refractive Index: 122c
• Transport Package: Negotiable
• Specification: >99%
• Trademark: QS-Clindamycin
• Origin: Xian
• Production Capacity: 1000kg/Month

Product Description

API CAS 24729-96-2 Clindamycin Pharmaceutical Clindamycin

Product Description

Product Details

Product Name	Clindamycin
Appearance	Clindamycin Powder
Assay	>99%
MW	504.96
MF	C18H34ClN2O8PS
Melting Point	114C
Boiling Point	159C

Clindamycin phosphate (clindamycinphosphate) is metabolized into active clindamycin upon entering the body, exhibiting potent antibacterial properties. It is effective against gram-positive bacteria like Staphylococcus aureus and Streptococcus, as well as anaerobic bacteria such as Bacteroides and Clostridium. It demonstrates strong antibacterial efficacy and lacks cross-allergic reactions with penicillin and cephalosporin antibiotics, making it a suitable alternative for penicillin-allergic patients.

Application&Function

1. Antibacterial Spectrum: 
Exhibits strong antibacterial activity against Gram-positive bacteria(such as Staphylococcus aureus and Streptococcus).  
Also shows significant efficacy against anaerobic bacteria(such as Bacteroides and Clostridium).  
Has weaker effects against some Gram-negative bacteria.
2. Mechanism of Action:
Clindamycin works by binding to the 50S subunit of the bacterial ribosome, inhibiting bacterial protein synthesis, thereby preventing bacterial growth and reproduction.
3. Clinical Applications:
Used to treat infections caused by susceptible bacteria, such as skin and soft tissue infections, respiratory tract infections, bone and joint infections, intra-abdominal infections, and gynecological infections.  
Particularly suitable for patients allergic to penicillin, as it does not exhibit cross-allergic reactions with penicillin or cephalosporin antibiotics.

Specification